Hematuria differential diagnosis: Difference between revisions
Aditya Ganti (talk | contribs) |
|||
Line 43: | Line 43: | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Immunoflourescence pattern | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Immunoflourescence pattern | ||
|- | |- | ||
| rowspan=" | | rowspan="43" style="background: #DCDCDC; padding: 5px; text-align: center;" |Hematuria | ||
| rowspan="9" style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Glomerular disease|Glomerular diseases]] | | rowspan="9" style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Glomerular disease|Glomerular diseases]] | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[IgA nephropathy|IgA nephropathy (Berger nephropathy)]] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[IgA nephropathy|IgA nephropathy (Berger nephropathy)]] | ||
Line 56: | Line 56: | ||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | - | ||
| colspan="2" style="background: #F5F5F5; padding: 5px;" | - | | colspan="2" style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" |- | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" |- | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Electron microscopy shows mesangial hypercellularity and increased mesangial matrix | * Electron microscopy shows mesangial hypercellularity and increased mesangial matrix | ||
Line 90: | Line 90: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* High-frequency sensorineural hearing loss | * High-frequency sensorineural hearing loss | ||
| colspan="2" style="background: #F5F5F5; padding: 5px;" |- | | colspan="2" style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Monoclonal antibodies directed against alpha-3 (IV), alpha-4 (IV), and alpha-5 (IV) chains of type IV collagen | * Monoclonal antibodies directed against alpha-3 (IV), alpha-4 (IV), and alpha-5 (IV) chains of type IV collagen | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Genetic Analysis | * Genetic Analysis | ||
| style="background: #F5F5F5; padding: 5px;" |- | | style="background: #F5F5F5; padding: 5px;" | - | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Poststreptococcal glomerulonephritis]] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Poststreptococcal glomerulonephritis]] | ||
| style="background: #F5F5F5; padding: 5px;" | +/- | | style="background: #F5F5F5; padding: 5px;" | +/- | ||
| style="background: #F5F5F5; padding: 5px;" | + | | style="background: #F5F5F5; padding: 5px;" | + | ||
| style="background: #F5F5F5; padding: 5px;" |- | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" |- | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" |+ | | style="background: #F5F5F5; padding: 5px;" | + | ||
| style="background: #F5F5F5; padding: 5px;" |+ | | style="background: #F5F5F5; padding: 5px;" | + | ||
| style="background: #F5F5F5; padding: 5px;" |+ | | style="background: #F5F5F5; padding: 5px;" | + | ||
| style="background: #F5F5F5; padding: 5px;" |+ | | style="background: #F5F5F5; padding: 5px;" | + | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Edema | * Edema | ||
Line 114: | Line 114: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Renal Biopsy | Renal Biopsy | ||
* Irregularly thin and attenuated GBM | * Irregularly thin and attenuated GBM | ||
Line 120: | Line 119: | ||
* Scarring | * Scarring | ||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" |- | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Hypercellularity of the glomeruli | * Hypercellularity of the glomeruli | ||
Line 130: | Line 129: | ||
* Starry sky pattern | * Starry sky pattern | ||
| style="background: #F5F5F5; padding: 5px;" |Biopsy | | style="background: #F5F5F5; padding: 5px;" |Biopsy | ||
| style="background: #F5F5F5; padding: 5px;" |- | | style="background: #F5F5F5; padding: 5px;" | - | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[MPGN|Mesangioproliferative glomerulonephritis]] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[MPGN|Mesangioproliferative glomerulonephritis]] | ||
Line 154: | Line 153: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Focal segmental glomerulosclerosis|Focal segmental glomerular sclerosis]] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Focal segmental glomerulosclerosis|Focal segmental glomerular sclerosis]] | ||
| style="background: #F5F5F5; padding: 5px;" |- | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" |- | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" |- | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" |- | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" |- | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" |- | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" |+ | | style="background: #F5F5F5; padding: 5px;" | + | ||
| style="background: #F5F5F5; padding: 5px;" |+ | | style="background: #F5F5F5; padding: 5px;" | + | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Nephrotic syndrome | * Nephrotic syndrome | ||
Line 176: | Line 175: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Shrunken kidneys | * Shrunken kidneys | ||
| style="background: #F5F5F5; padding: 5px;" |- | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" |- | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Segmental solidification in the perihilar region and peripheral areas, specially the tubular pole | * Segmental solidification in the perihilar region and peripheral areas, specially the tubular pole | ||
Line 187: | Line 186: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Rapidly progressive glomerulonephritis]] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Rapidly progressive glomerulonephritis]] | ||
| style="background: #F5F5F5; padding: 5px;" |+ | | style="background: #F5F5F5; padding: 5px;" | + | ||
| style="background: #F5F5F5; padding: 5px;" |+ | | style="background: #F5F5F5; padding: 5px;" | + | ||
| style="background: #F5F5F5; padding: 5px;" |+ | | style="background: #F5F5F5; padding: 5px;" | + | ||
| style="background: #F5F5F5; padding: 5px;" |- | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" |- | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" |- | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" |+ | | style="background: #F5F5F5; padding: 5px;" | + | ||
| style="background: #F5F5F5; padding: 5px;" |- | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Abdominal pain | * Abdominal pain | ||
Line 209: | Line 208: | ||
* Proteinuria | * Proteinuria | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" |- | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" |- | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" |- | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" |Diffuse, proliferative, necrotizing glomerulonephritis with crescent formation | | style="background: #F5F5F5; padding: 5px;" |Diffuse, proliferative, necrotizing glomerulonephritis with crescent formation | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 514: | Line 513: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| rowspan=" | | rowspan="5" style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Vascular anomaly|Vascular diseases]] | ||
| rowspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Renal vein thrombosis]] | | rowspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Renal vein thrombosis]] | ||
| rowspan="2" style="background: #F5F5F5; padding: 5px;" | + | | rowspan="2" style="background: #F5F5F5; padding: 5px;" | + | ||
Line 543: | Line 542: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 569: | Line 547: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Polyarteritis nodosa]] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Polyarteritis nodosa]] | ||
| style="background: #F5F5F5; padding: 5px;" |- | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" |-/+ | | style="background: #F5F5F5; padding: 5px;" | -/+ | ||
| style="background: #F5F5F5; padding: 5px;" |- | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" |- | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" |- | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" |+ | | style="background: #F5F5F5; padding: 5px;" | + | ||
| style="background: #F5F5F5; padding: 5px;" |+ | | style="background: #F5F5F5; padding: 5px;" | + | ||
| style="background: #F5F5F5; padding: 5px;" |- | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* [[Fatigue (physical)|Fatigue]] | * [[Fatigue (physical)|Fatigue]] | ||
Line 897: | Line 875: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Prostatitis]] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Prostatitis]] | ||
| style="background: #F5F5F5; padding: 5px;" | - | |||
| style="background: #F5F5F5; padding: 5px;" | + | |||
| style="background: #F5F5F5; padding: 5px;" | - | |||
| style="background: #F5F5F5; padding: 5px;" | + | |||
| style="background: #F5F5F5; padding: 5px;" | + | |||
| style="background: #F5F5F5; padding: 5px;" | + | |||
| style="background: #F5F5F5; padding: 5px;" | - | |||
| style="background: #F5F5F5; padding: 5px;" | - | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Body aches | |||
| colspan="2" style="background: #F5F5F5; padding: 5px;" | | |||
* Increased [[leukocytes]] (>10 per high power field) on CBC | |||
* Bacteria seen on [[urine culture]] | |||
* Elevated [[C-reactive protein]] | |||
* Transiently elevated [[PSA]] (prostate specific antigen) levels | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Focal hypoechoic region located in the peripheral part of the [[prostate]] | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Edema of the [[prostate gland]] with diffuse enlargement,. | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Hyperintense lesions on MRI | |||
| colspan="2" style="background: #F5F5F5; padding: 5px;" | | |||
* [[Neutrophils]] | |||
* Between the epithelial cells or inside the stroma. | |||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 1,066: | Line 1,052: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| rowspan=" | | rowspan="14" style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Dark urine]] | ||
| rowspan=" | | rowspan="6" style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Hemoglobinuria]] | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Autoimmune hemolytic anemia]] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Autoimmune hemolytic anemia]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 1,194: | Line 1,180: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| rowspan="8" style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Myoglobinuria]] | |||
| rowspan=" | |||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Crush injury]] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Crush injury]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 1,364: | Line 1,329: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Haff disease]] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Haff disease]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | |
Revision as of 20:03, 20 July 2018
Hematuria Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Hematuria differential diagnosis On the Web |
American Roentgen Ray Society Images of Hematuria differential diagnosis |
Risk calculators and risk factors for Hematuria differential diagnosis |
Steven C. Campbell, M.D., Ph.D. Associate Editor(s)-in-Chief: Venkata Sivakrishna Kumar Pulivarthi M.B.B.S [1]
Overview
Gross hematuria(GH) must be distinguished from pigmenturia, which may be due to endogenous sources (e.g., bilirubin, myoglobin,and porphyrins), foods ingested (e.g., beets and rhubarb), drugs (e.g., phenazopyridine), and simple dehydration. This distinction can be made easily by urinalysis with microscopy. Notably, myoglobinuria and other factors can cause false-positive chemical tests for hemoglobin, so urine microscopy is required to confirm the diagnosis of hematuria. GH also must be distinguished from vaginal bleeding in women, which usually can be achieved by obtaining a careful menstrual history, collecting the specimen when the patient is not having menstrual or gynecologic bleeding, or, if necessary, obtaining a catheterized specimen. GH may also be detected by the presence of blood spotting on the undergarments of incontinent patients. After ruling out vaginal bleeding and mimics of hematuria, a urologic source must be suspected.
Differential Diagnosis
Hematuria should be differentiated from other disease which mimic hematuria especially hemoglobinuria and myoglobinuria which are dipstick positive but negative for microscopy.
Hematuria differential diagnosis
Differentiating the diseases that can cause hematuria:
Diseases | Clinical manifestations | Para-clinical findings | Gold standard | Additional findings | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Symptoms | Physical examination | ||||||||||||||||||||
Lab Findings | Imaging | Histopathology | |||||||||||||||||||
Low back pain | Fever | Nausea/Vomiting | Urinary symptoms | Hypertension | Pitting edema | Other | Ultrasonography | CT scan | Other | ||||||||||||
Dysuria | Frequency | Oliguria | Light microscopy | Immunoflourescence pattern | |||||||||||||||||
Hematuria | Glomerular diseases | IgA nephropathy (Berger nephropathy) | + | - | - | - | + | + | + | - | - | - | - |
|
|
|
Biopsy | - | |||
Hereditary nephritis (Alport syndrome) | - | - | - | - | - | - | + | - |
|
|
- |
|
- |
|
|
- | |||||
Poststreptococcal glomerulonephritis | +/- | + | - | - | + | + | + | + |
|
|
Renal Biopsy
|
- | - |
|
|
Biopsy | - | ||||
Mesangioproliferative glomerulonephritis | |||||||||||||||||||||
Focal segmental glomerular sclerosis | - | - | - | - | - | - | + | + |
|
|
|
- | - |
|
|
Biopsy | - | ||||
Rapidly progressive glomerulonephritis | + | + | + | - | - | - | + | - |
|
|
- | - | - | Diffuse, proliferative, necrotizing glomerulonephritis with crescent formation | - | Biospy | 80% of patients have ANCA-positive microscopic polyangiitis | ||||
Lupus nephritis | |||||||||||||||||||||
Thin basement membrane disease | |||||||||||||||||||||
Fabry disease | |||||||||||||||||||||
Tubulointerstitial diseases | Renal papillary necrosis | ||||||||||||||||||||
Acute interstitial nephritis | + | + | + | ||||||||||||||||||
Analgesic | |||||||||||||||||||||
Nephrolithiasis | |||||||||||||||||||||
Reflux nephropathy (hydronephrosis) | |||||||||||||||||||||
Malignancy | Renal cell carcinoma (RCC) | ||||||||||||||||||||
Nephroblastoma | |||||||||||||||||||||
Transitional cell carcinoma (TCC) | |||||||||||||||||||||
Prostate cancer | |||||||||||||||||||||
Familial diseases | Polycystic kidney disease | + | - | - | - | - | - | + | + |
|
|
|
Genetic testing demonstrates: |
|
|
Ultrasound | |||||
Vascular diseases | Renal vein thrombosis | + | + | + | - | - | - | - | - |
|
|
|
|
||||||||
Polyarteritis nodosa | - | -/+ | - | - | - | + | + | - |
|
||||||||||||
Wegner's granulomatosis polyangiitis | |||||||||||||||||||||
Henoch-Schönlein purpura | |||||||||||||||||||||
Lower urinary tract diseases | Benign prostatic hyperplasia | ||||||||||||||||||||
Urolithiasis | |||||||||||||||||||||
Interstitial cystitis | |||||||||||||||||||||
Radiogenic cystitis | |||||||||||||||||||||
Systemic diseases | Coagulopathy (hemophilia) | ||||||||||||||||||||
Sickle cell anemia | |||||||||||||||||||||
Abdominal aortic aneurysm | |||||||||||||||||||||
Lymphomas | |||||||||||||||||||||
Multiple myeloma | |||||||||||||||||||||
Infectious diseases | Pyelonephritis | + | + | + | + | + | + | - | - |
|
|
Contrast nephrograms
|
|
- | |||||||
Cystitis | - | - | - | + | + | + | - | - |
|
|
|
MRI
|
|||||||||
Prostatitis | - | + | - | + | + | + | - | - |
|
|
|
|
|
|
|||||||
Urethritis | |||||||||||||||||||||
Epididymitis | |||||||||||||||||||||
Cytomegalovirus | |||||||||||||||||||||
Infectious mononucleosis | |||||||||||||||||||||
Condylomata acuminata | |||||||||||||||||||||
Urogenital trauma | Inserted bladder or ureteral catheters | ||||||||||||||||||||
Drugs | Anticoagulants | ||||||||||||||||||||
Dark urine | Hemoglobinuria | Autoimmune hemolytic anemia | |||||||||||||||||||
Microangiopathic hemolytic anemia | |||||||||||||||||||||
Thrombotic thrombocytopenic purpura | |||||||||||||||||||||
Paroxysmal nocturnal hemoglobinuria | |||||||||||||||||||||
Paroxysmal cold hemoglobinuria | |||||||||||||||||||||
Falciparum malaria | |||||||||||||||||||||
Myoglobinuria | Crush injury | ||||||||||||||||||||
Vigorous muscle exercise | |||||||||||||||||||||
Hyperthermia (Heat stroke) | |||||||||||||||||||||
Electric shock | |||||||||||||||||||||
Prolonged seizure | |||||||||||||||||||||
Polymyositis | |||||||||||||||||||||
Trichinosis | |||||||||||||||||||||
Haff disease |